Welopt Eye Drop contains Olopatadine 0.2% w/v, an antihistamine and mast cell stabilizer indicated for the treatment of allergic conjunctivitis. Olopatadine acts by selectively inhibiting the release of histamine from mast cells and blocking H1 histamine receptors, thereby reducing ocular itching, redness, and swelling associated with allergic reactions. Welopt Eye Drop is effective in alleviating symptoms such as eye itching, tearing, and redness caused by seasonal or perennial allergic conjunctivitis. The formulation provides rapid relief and sustained action, making it suitable for both acute and chronic allergic eye conditions. It is generally well tolerated, with minimal side effects including mild transient burning or stinging upon instillation. Welopt Eye Drop should be administered as directed by a healthcare professional, typically one drop in the affected eye(s) twice daily. Caution is advised in patients with hypersensitivity to Olopatadine or any component of the formulation. Contact lens wearers should remove lenses prior to application and may reinsert lenses after 15 minutes. Use during pregnancy and lactation should be under medical supervision. Welopt Eye Drop offers an effective therapeutic option for managing allergic conjunctivitis, improving patient comfort and ocular health.